fig4

Sex and gender differences in MASLD: pathophysiological mechanisms, clinical implications, and future directions

Figure 4. Overview of Cardio-Metabolic and Extrahepatic Comorbidities in MASLD: Sex-Specific Risk Patterns. This figure provides a concise summary of the major systemic comorbidities associated with MASLD, with an emphasis on sex-related differences in risk. ↑Indicates that the risk of the specified MASLD-related complication is higher in the mentioned sex compared with the other sex. MASLD: Metabolic dysfunction-associated steatotic liver disease; CVD: cardiovascular disease; CKD: chronic kidney disease; HCC: hepatocellular carcinoma.

Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/